Innovative Cancer Treatment Targets Protein Interactions to Halt Tumor Growth
TL;DR
Scientists have developed a targeted cancer therapy that inhibits the interaction between the RAS gene and a key pathway, successfully stopping tumor growth in mice without harming healthy cells, and it is now entering human clinical trials.
- Breakthrough cancer therapy stops tumor growth without harming healthy cells Science Daily
- A New Way To Stop Cancer Growth: Groundbreaking Drug Enters Human Trials SciTechDaily
- Vividion Announces Publication in Science of Preclinical Data on Covalent Inhibitors of RAS-PI3K that Block Tumor Growth Business Wire
- New Drug Candidate Blocks RAS-PI3K Interaction that Fuels Tumor Growth Inside Precision Medicine
- Breakthrough in cancer therapy targets key protein interaction to suppress tumors News-Medical
Want the full story? Read the original reporting
Read on Science Daily